EXACTLE-Trial: Main results. How can EXACTLE help in AATD patients' treatment?

A. Dirksen (Hellerup, Denmark)

Source: Annual Congress 2008 - EXACTLE: EXAcerbations and CT scans as Lung Endpoints in Alpha-1-Antitrypsin Deficiency
Disease area: Airway diseases

Slide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Dirksen (Hellerup, Denmark). EXACTLE-Trial: Main results. How can EXACTLE help in AATD patients' treatment?. Annual Congress 2008 - EXACTLE: EXAcerbations and CT scans as Lung Endpoints in Alpha-1-Antitrypsin Deficiency

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014


Disease management program COPD in Germany: benefit for the patient in respect of GOLD-stages?
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019


Patients’ adherence to treatment: How does it changes in 1 year after finishing of the participation in trial?
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013

Characteristics of effective self-management interventions in patients with COPD: individual patient data meta-analysis
Source: Eur Respir J 2016; 48: 55-68
Year: 2016



GOLD BCD or 234 classifications: Which one better reflects COPD patients' functionality?
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014


Late Breaking Abstract - Second Souffle: preliminary results from a national survey on the care pathways and quality of life of patients with T2 severe asthma
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


Can pulmonary rehabilitation (PR) provide the patient's ability to better cope COPD? – A longitudinal design
Source: International Congress 2014 – From individual patient interactions to models of care: the nursing perspective
Year: 2014

"Trial-skilled" patients: How big the improvement in cooperation?
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013

We provided patients with patients oriented diagnosis and treatment advice from their lung assessments using an algorithm. It was feasible and in general well appreciated by our patients
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016


Prescriptions for treatment in patients with PCD: does clinical routine match recommendations?
Source: Virtual Congress 2020 – Worldwide respiratory disease across the full spectrum
Year: 2020


Quality of life in lung cancer patients: preliminary results of a multi-professional interview for diagnosis disclosure (MIDD)
Source: Eur Respir J 2005; 26: Suppl. 49, 459s
Year: 2005

An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Real-world effects of tezacaftor/ivacaftor (TEZ/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021


Real-world effects of lumacaftor/ivacaftor (LUM/IVA) in people with cystic fibrosis (pwCF): interim results of a long-term safety study using US CF Foundation Patient Registry (CFFPR) data
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021


COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Loneliness and lack of social support severely influences patients’ quality of life. Secondary findings from our focusgroup study in asthma and COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016


Sarcoidosis treatment and outcomes: what is most important to patients?
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018



Is integrated disease management of COPD effective? Results of the RECODE cluster randomized controlled trial in real world patients
Source: International Congress 2014 – Diagnosing and managing asthma and COPD in primary care
Year: 2014